Late mortality after COVID-19 infection in veterans vs risk-matched comparators

About The Study: The findings of this study indicate that COVID-19 was not associated with any clinically significant excess mortality among those who survived at least 180 days compared with closely risk-matched comparators, despite having worse 2-year total mortality. This finding has individual level and health system planning implications and should be reassuring to persons who have survived COVID-19 for at least 180 days. 

Authors: Theodore J. Iwashyna, M.D., Ph.D., of the Ann Arbor VA in Ann Arbor, Michigan, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamainternmed.2023.3587)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2023.3587?guestAccessKey=824bb594-a5f5-482b-8e2f-f8ec0f561efd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082123

END